Navigation Links
KICVentures Ramps Up AxioMed Freedom Cervical Disc Manufacturing to Meet OUS Orders and Expand Market Share Rapidly
Date:12/27/2018

AxioMed completed its initial production of the first 60 cervical discs for implantation at its new Boston facility, and is now raising growth capital to ramp up demand for orders already placed, and to have additional inventory to immediately expand market share against inferior ball and socket discs. The capital raise is targeted to qualified private investors with a $50,000 minimum per investor. This sum encourages more participation vs. institutions with deeper pockets because Dr. Chin, Managing Partner and CEO of KICVentures (AxioMed's parent company) believes this disc should have a grass roots success story.

About AxioMed LLC

AxioMed was founded to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first-generation artificial discs. Led by an experienced surgeon team and utilizing patented viscoelastic polymer technology, AxioMed has developed the next generation of artificial discs. AxioMed completed its U.S. IDE for the Lumbar Disc with over five years of clinical follow-up.

About KICVentures

KICVentures is a private investment company founded in 2005 by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin, who brings unique experience at the intersection of medicine, business and information technology. KICVentures is equipped with a strong advantage in identifying niche healthcare opportunities, and is headquartered in Boston, Mass.

Read the full story at https://www.prweb.com/releases/kicventures_ramps_up_axiomed_freedom_cervical_disc_manufacturing_to_meet_ous_orders_and_expand_market_share_rapidly/prweb15997208.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. DFG and Leopoldina: Recommendations on scientific freedom and scientific responsibility
2. Genetic circuit allows both individual freedom, collective good
3. Study shows Hera Therapeutics compound combats HPV types that cause most cervical cancer
4. Clearing cells to prevent cervical cancer
5. Current guidelines underestimate US cervical cancer incidence and older womens risk
6. Radiation therapy for cervical cancer increases risk for colorectal cancer
7. LSUHSC research reveals structure of master regulator and new drug target for autism, cervical cancer
8. International team completes systematic, genomic study of cervical cancer
9. Biocompare Releases Documentary on “What Researchers Need to Know about Antibody Manufacturing”
10. RoosterBio Inc. and Tissue Regeneration Therapeutics Inc. Announce Alliance Around Scale-up Manufacturing of Umbilical Cord Tissue Perivascular Cell Technology
11. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/4/2019)... (PRWEB) , ... June 04, 2019 , ... ... today announced the appointment of Susan Murphy as the new President of Molecular ... Sciences?owned by Molecular Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices ...
(Date:6/4/2019)... TORONTO (PRWEB) , ... June 04, 2019 , ... ... automate the search for salient features of seizure risk signals, usually based on ... neurologist-driven EEG interpretation remains the only acceptable diagnostic methodology due to the complexity ...
(Date:6/3/2019)... (PRWEB) , ... June 03, 2019 , ... Stay on ... biotech, medical device and food industries. Access to all webinars is free, so be ... relevant in your field! , Visit http://www.xtalks.com to see our upcoming webinars: ...
Breaking Biology News(10 mins):
(Date:5/21/2019)... ... May 21, 2019 , ... DuPont Nutrition & ... the inaugural Africa Brewing Conference dedicated to sharing brewing knowledge, strengthening relationships and ... which is supported through a partnership with “Ethiopia Invest”, will run through May ...
(Date:5/14/2019)... ... 14, 2019 , ... Gateway Genomics , a leading developer of prenatal ... to 5,000 square feet. , “This past year has seen exponential growth for ... CEO, Chris Jacob. “The SneakPeek At-Home test, which is mailed directly to our customers ...
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys ... Diopsys® ffERG/Photopic Negative Response vision test, a new full field electroretinography ... is estimated that 6.3 million Americans will have glaucoma, with black Americans having ...
(Date:5/2/2019)... ... May 02, 2019 , ... Researchers from Ambry ... discrepancies between U.S. insurer policies for genetic testing and the 2019 National Comprehensive ... and ovarian cancer (HBOC). , Jill S. Dolinsky, director of clinical ...
Breaking Biology Technology: